Symmetrical lysine cation antibacterial peptide simulant with antibiotic synergistic activity and preparation method thereof
The invention belongs to the technical field of medicinal chemistry, and relates to a symmetrical lysine cation antibacterial peptide simulant with antibiotic synergistic activity and a preparation method of the symmetrical lysine cation antibacterial peptide simulant. An in-vitro antibacterial acti...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HATAKAMI TAKASHI ZHANG TINGTING DU XIANGDANG SHEN BOYUAN LI SEN ZHANG EN KONG HONGTAO LI SHIHONG YAN DACHAO YAO HONG YAN TINGTING |
| description | The invention belongs to the technical field of medicinal chemistry, and relates to a symmetrical lysine cation antibacterial peptide simulant with antibiotic synergistic activity and a preparation method of the symmetrical lysine cation antibacterial peptide simulant. An in-vitro antibacterial activity experiment proves that the compound can enhance the activity of minocycline on gram-negative bacteria resistant to tetracycline antibiotics, such as carbapenem-resistant klebsiella pneumoniae, so that the MIC (minimal inhibitory concentration) of the minocycline is reduced by 8-128 times, and the compound 329 has better tetracycline antibiotic synergistic activity. A toxicity experiment result shows that the compound 329 hardly has hemolytic toxicity and has relatively low cytotoxicity. Mechanism research experiments find that the compound acts on bacterial cell membranes, permeability of outer membranes and inner membranes is increased, meanwhile, accumulation of minocycline in bacterial cells is promoted, an |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN115197091A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN115197091A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN115197091A3</originalsourceid><addsrcrecordid>eNqNjU0KwjAQhbtxIeodxgMIBhHpUoriyo3uy5hO7UD-SEYl4OGN1AO4eg--9zOt3pdsLUlkjQZMTuwINAp7B-iEb6iFIhcWKAh3BIntwxQEL5ZhzLAX1pCyo3jn9PWlxU-WXHgHIVLAOG6Wq8F3IANF8v28mvRoEi1-OquWx8O1Oa0o-JZSQE2OpG3OSm1VvVvXar_5J_MBCttJlw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Symmetrical lysine cation antibacterial peptide simulant with antibiotic synergistic activity and preparation method thereof</title><source>esp@cenet</source><creator>HATAKAMI TAKASHI ; ZHANG TINGTING ; DU XIANGDANG ; SHEN BOYUAN ; LI SEN ; ZHANG EN ; KONG HONGTAO ; LI SHIHONG ; YAN DACHAO ; YAO HONG ; YAN TINGTING</creator><creatorcontrib>HATAKAMI TAKASHI ; ZHANG TINGTING ; DU XIANGDANG ; SHEN BOYUAN ; LI SEN ; ZHANG EN ; KONG HONGTAO ; LI SHIHONG ; YAN DACHAO ; YAO HONG ; YAN TINGTING</creatorcontrib><description>The invention belongs to the technical field of medicinal chemistry, and relates to a symmetrical lysine cation antibacterial peptide simulant with antibiotic synergistic activity and a preparation method of the symmetrical lysine cation antibacterial peptide simulant. An in-vitro antibacterial activity experiment proves that the compound can enhance the activity of minocycline on gram-negative bacteria resistant to tetracycline antibiotics, such as carbapenem-resistant klebsiella pneumoniae, so that the MIC (minimal inhibitory concentration) of the minocycline is reduced by 8-128 times, and the compound 329 has better tetracycline antibiotic synergistic activity. A toxicity experiment result shows that the compound 329 hardly has hemolytic toxicity and has relatively low cytotoxicity. Mechanism research experiments find that the compound acts on bacterial cell membranes, permeability of outer membranes and inner membranes is increased, meanwhile, accumulation of minocycline in bacterial cells is promoted, an</description><language>chi ; eng</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221018&DB=EPODOC&CC=CN&NR=115197091A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20221018&DB=EPODOC&CC=CN&NR=115197091A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HATAKAMI TAKASHI</creatorcontrib><creatorcontrib>ZHANG TINGTING</creatorcontrib><creatorcontrib>DU XIANGDANG</creatorcontrib><creatorcontrib>SHEN BOYUAN</creatorcontrib><creatorcontrib>LI SEN</creatorcontrib><creatorcontrib>ZHANG EN</creatorcontrib><creatorcontrib>KONG HONGTAO</creatorcontrib><creatorcontrib>LI SHIHONG</creatorcontrib><creatorcontrib>YAN DACHAO</creatorcontrib><creatorcontrib>YAO HONG</creatorcontrib><creatorcontrib>YAN TINGTING</creatorcontrib><title>Symmetrical lysine cation antibacterial peptide simulant with antibiotic synergistic activity and preparation method thereof</title><description>The invention belongs to the technical field of medicinal chemistry, and relates to a symmetrical lysine cation antibacterial peptide simulant with antibiotic synergistic activity and a preparation method of the symmetrical lysine cation antibacterial peptide simulant. An in-vitro antibacterial activity experiment proves that the compound can enhance the activity of minocycline on gram-negative bacteria resistant to tetracycline antibiotics, such as carbapenem-resistant klebsiella pneumoniae, so that the MIC (minimal inhibitory concentration) of the minocycline is reduced by 8-128 times, and the compound 329 has better tetracycline antibiotic synergistic activity. A toxicity experiment result shows that the compound 329 hardly has hemolytic toxicity and has relatively low cytotoxicity. Mechanism research experiments find that the compound acts on bacterial cell membranes, permeability of outer membranes and inner membranes is increased, meanwhile, accumulation of minocycline in bacterial cells is promoted, an</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjU0KwjAQhbtxIeodxgMIBhHpUoriyo3uy5hO7UD-SEYl4OGN1AO4eg--9zOt3pdsLUlkjQZMTuwINAp7B-iEb6iFIhcWKAh3BIntwxQEL5ZhzLAX1pCyo3jn9PWlxU-WXHgHIVLAOG6Wq8F3IANF8v28mvRoEi1-OquWx8O1Oa0o-JZSQE2OpG3OSm1VvVvXar_5J_MBCttJlw</recordid><startdate>20221018</startdate><enddate>20221018</enddate><creator>HATAKAMI TAKASHI</creator><creator>ZHANG TINGTING</creator><creator>DU XIANGDANG</creator><creator>SHEN BOYUAN</creator><creator>LI SEN</creator><creator>ZHANG EN</creator><creator>KONG HONGTAO</creator><creator>LI SHIHONG</creator><creator>YAN DACHAO</creator><creator>YAO HONG</creator><creator>YAN TINGTING</creator><scope>EVB</scope></search><sort><creationdate>20221018</creationdate><title>Symmetrical lysine cation antibacterial peptide simulant with antibiotic synergistic activity and preparation method thereof</title><author>HATAKAMI TAKASHI ; ZHANG TINGTING ; DU XIANGDANG ; SHEN BOYUAN ; LI SEN ; ZHANG EN ; KONG HONGTAO ; LI SHIHONG ; YAN DACHAO ; YAO HONG ; YAN TINGTING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN115197091A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HATAKAMI TAKASHI</creatorcontrib><creatorcontrib>ZHANG TINGTING</creatorcontrib><creatorcontrib>DU XIANGDANG</creatorcontrib><creatorcontrib>SHEN BOYUAN</creatorcontrib><creatorcontrib>LI SEN</creatorcontrib><creatorcontrib>ZHANG EN</creatorcontrib><creatorcontrib>KONG HONGTAO</creatorcontrib><creatorcontrib>LI SHIHONG</creatorcontrib><creatorcontrib>YAN DACHAO</creatorcontrib><creatorcontrib>YAO HONG</creatorcontrib><creatorcontrib>YAN TINGTING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HATAKAMI TAKASHI</au><au>ZHANG TINGTING</au><au>DU XIANGDANG</au><au>SHEN BOYUAN</au><au>LI SEN</au><au>ZHANG EN</au><au>KONG HONGTAO</au><au>LI SHIHONG</au><au>YAN DACHAO</au><au>YAO HONG</au><au>YAN TINGTING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Symmetrical lysine cation antibacterial peptide simulant with antibiotic synergistic activity and preparation method thereof</title><date>2022-10-18</date><risdate>2022</risdate><abstract>The invention belongs to the technical field of medicinal chemistry, and relates to a symmetrical lysine cation antibacterial peptide simulant with antibiotic synergistic activity and a preparation method of the symmetrical lysine cation antibacterial peptide simulant. An in-vitro antibacterial activity experiment proves that the compound can enhance the activity of minocycline on gram-negative bacteria resistant to tetracycline antibiotics, such as carbapenem-resistant klebsiella pneumoniae, so that the MIC (minimal inhibitory concentration) of the minocycline is reduced by 8-128 times, and the compound 329 has better tetracycline antibiotic synergistic activity. A toxicity experiment result shows that the compound 329 hardly has hemolytic toxicity and has relatively low cytotoxicity. Mechanism research experiments find that the compound acts on bacterial cell membranes, permeability of outer membranes and inner membranes is increased, meanwhile, accumulation of minocycline in bacterial cells is promoted, an</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN115197091A |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Symmetrical lysine cation antibacterial peptide simulant with antibiotic synergistic activity and preparation method thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T07%3A20%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HATAKAMI%20TAKASHI&rft.date=2022-10-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN115197091A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |